Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02BPX
|
|||
| Former ID |
DIB000292
|
|||
| Drug Name |
NGM 282
|
|||
| Indication | Primary biliary cirrhosis [ICD-11: DB96.1; ICD-10: K74.3; ICD-9: 571.6] | Phase 2 | [1] | |
| Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 2 | [2] | ||
| Company |
Ngm biopharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800037506) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.